abstract |
A novel antineoplastic agent comprising at least one receptor B7h ligand, the B7h receptor ligand is loaded on a biocompatible microcarrier or nanocarrier and binds to receptor B7h to trigger receptor B7h activity. It is possible, a novel antitumor agent. |